Department of Pharmacy, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
Am J Physiol Renal Physiol. 2010 Apr;298(4):F923-34. doi: 10.1152/ajprenal.00567.2009. Epub 2010 Jan 13.
To clarify the specific molecular events of progressive tubular damage in chronic renal failure (CRF), we conducted microarray analyses using isolated proximal tubules from subtotally nephrectomized (Nx) rats as a model of CRF. Our results clearly demonstrated time-dependent changes in gene expression profiles localized to proximal tubules. The expression of mitosis-specific genes Cyclin B2 and Cell division cycle 2 (Cdc2) was significantly and selectively increased in the proximal tubules during the compensated period but decreased to basal level in the end-stage period. Administration of everolimus, a potent inhibitor of mammalian target of rapamycin, markedly reduced compensatory hypertrophy and hyperplasia of epithelial cells, which was accompanied by complete abolishment of the expression of Cyclin B2 and Cdc2 enhancement; renal function was then severely decreased. Treatment with the Cdc2 inhibitor 2-cyanoethyl alsterpaullone clearly decreased epithelial cell hyperplasia, based on staining of phosphorylated histone H3 and Ki-67, while hypertrophy was not inhibited. In conclusion, we have demonstrated roles of Cyclin B2 and Cdc2 in the epithelial hyperplasia in response to Nx. These results advance the knowledge of the contribution of cell cycle regulators, especially M phase, in pathophysiology of tubular restoration and/or degeneration, and these two molecules are suggested to be a marker for the proliferation of proximal tubular cells in CRF.
为了阐明慢性肾衰竭(CRF)进行性管状损伤的具体分子事件,我们使用分离的部分肾切除(Nx)大鼠的近端小管进行了微阵列分析,作为 CRF 的模型。我们的结果清楚地表明,基因表达谱在时间上有近端小管的定位变化。有丝分裂特异性基因 Cyclin B2 和细胞分裂周期蛋白 2(Cdc2)的表达在代偿期明显且选择性地增加,但在终末期降至基础水平。哺乳动物雷帕霉素靶蛋白的强效抑制剂 everolimus 的给药显著减少了上皮细胞的代偿性肥大和增生,这伴随着 Cyclin B2 和 Cdc2 增强表达的完全消除;随后肾功能严重下降。用 Cdc2 抑制剂 2-氰乙基 alsterpaullone 处理明显减少了磷酸化组蛋白 H3 和 Ki-67 的染色阳性的上皮细胞增生,而没有抑制肥大。总之,我们已经证明了 Cyclin B2 和 Cdc2 在对 Nx 的上皮细胞增生中的作用。这些结果提高了细胞周期调节剂,特别是 M 期在管状修复和/或退化的病理生理学中的作用的认识,这两个分子被建议作为 CRF 近端肾小管细胞增殖的标志物。